Medable has introduced the Medable Partner Network, combining a varied ecosystem of technology, service, data, site, and direct-to-patient partners that collaborate to expedite decentralised clinical trial deployment.
These collaborators share Medable’s goal of delivering efficient treatments to patients quickly.
To be successful, pharma and biotech sponsors require scalability, quicker time to market, reduced operating expenses and new technology and service partners, the company noted.
Medable aids sponsors to build, introduce and manage trials based on an established clinical trials platform, adaptable applications, expanded partner ecosystem and round the clock worldwide support.
Leveraging remote trial access, user experiences and various services, connected devices and data sources, the Medable Partner Network permits sponsors to mount their approaches to put patients at the centre of care.
The network categories comprise service partners, data partners, technology partners, direct-to-patient partners and site partners.
Medable chief strategy officer MaryAnne Rizk said: “The next stage of clinical trial transformation is collaboration at scale.
“Accelerating innovation requires an ecosystem, so we’ve created the Medable Partner Network to simplify collaboration for both sponsors and partners.
“Our ecosystem of certified partners allows us to innovate faster together, so we can deliver smarter trials to meet the needs of patients and address the biggest challenges in healthcare.”
The latest development comes after Medable and CVS Health signed a partnership to expand access and engagement to trials for patients at chosen MinuteClinic locations using the former’s clinical trials software platform.